ArticleJournal of lipid research2015

Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.

Masato Furuhashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.